Atai Life Sciences N.V. financials at a glance

+ Portfolio

The revenue of Atai Life Sciences N.V. is reported as 0.00021 billion Dollars in the fiscal year 2023. The earnings were -0.25 Dollars per share in 2023, which was 74.49 higher than 2022. And about -0.08429 billion Dollars are reported as free cash flow in the financials of Atai Life Sciences N.V. 2023. No dividends were paid to the shareholders of the Atai Life Sciences N.V. stock NasdaqGM:ATAI in the financial year 2023.

$0.21M

Revenue

$-0.25

Earnings Per Share

100.00%

Gross Margin %

$-85.60M

Free Cash Flow

Revenue

0.21

Earnings Per Share

-0.25

Gross Margin %

100.00

Free Cash Flow

-85.60

Financials

Year	Year	TTM	2023	2022	2021
Rev.	Revenue	N/A	$0.21M	$0.23M	$20.38M
GM %	Gross Margin %	100.00%	100.00%	100.00%	100.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-0.43	$-0.25	$-0.98	$-1.21
Div.	Dividends	N/A	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	-0.00%	-0.00%
Sha.	Shares	N/AM	166.03M	166.01M	160.71M
OCF	Operating Cash Flow	N/A	$-84.12M	$-,104.47M	$-63.25M
FCF	Free Cash Flow	N/A	$-85.60M	$-,105.24M	$-63.42M
FCFS	Free Cash Flow Per Share	$-0.60	$-0.53	$-0.68	$-0.47

Atai Life Sciences N.V. financials at a glance

Financials

Discover